treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk...
.
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
..
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..